Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 14
2 Introduction 16
2.1 What Is This Report
About? 16
3 Definitions of Markets Covered in the Report 17
3.1
Cardiovascular Devices 17
3.2 Cardiac Rhythm Management 17
3.3
Cardiovascular monitoring and diagnostic devices 17
3.4 Cardiovascular
prosthetic device 17
3.5 Cardiovascular Surgery 17
3.6
Electrophysiology 17
3.7 Interventional cardiology 17
3.8 Peripheral
vascular devices 18
4 Cardiovascular Devices in North America 19
4.1
Cardiovascular Devices, North America, Overall Revenue ($ mn), 2000-2015
19
4.2 Cardiovascular Devices, North America, Category Volume (Units),
2000-2015 25
4.3 Cardiovascular Devices, North America, Company share
(2007-2008) 30
5 Cardiovascular Devices In United States 31
5.1
Cardiovascular Devices, United States, Overall Revenue ($ mn), 2000-2015
31
5.2 Cardiovascular Devices, United States, Category Volume (Units),
2000-2015 36
5.3 Cardiovascular Devices, United States, Distribution Share
(2006-2007) 40
5.3.1 Cardiac Rhythm Management Distribution Share
(2006-2007) 40
5.3.2 Cardiovascular Monitoring and Diagnostic Devices
Distribution Share (2006-2007) 40
5.3.3 Cardiovascular Prosthetic Devices
Distribution Share (2006-2007) 41
5.3.4 Cardiovascular Surgery
Distribution Share (2006-2007) 41
5.3.5 Electrophysiology Distribution
Share (2006-2007) 42
5.3.6 Interventional Cardiology Distribution Share
(2006-2007) 42
5.3.7 Peripheral Vascular Devices Distribution Share
(2006-2007) 43
5.4 Cardiovascular Devices, United States, Company Share
(2007-2008) 44
5.4.1 Cardiovascular Devices, United States, Company Share
(2007-2008) 44
5.4.2 Cardiac Rhythm Management, United States, Company
Share (2007-2008) 45
5.4.3 Cardiovascular Monitoring and Diagnostic
Devices, United States, Company Share (2007-2008) 46
5.4.4 Cardiovascular
Prosthetic Devices, United States, Company Share (2007-2008) 48
5.4.5
Cardiovascular Surgery, United States, Company Share (2007-2008) 50
5.4.6
Electrophysiology, United States, Company Share (2007-2008) 51
5.4.7
Interventional Cardiology, United States, Company Share (2007-2008) 52
5.4.8 Peripheral Vascular Devices, United States, Company Share (2007-2008)
53
6 Cardiovascular Devices In Canada 54
6.1 Cardiovascular Devices,
Canada, Overall Revenue ($ mn), 2000-2015 54
6.2 Cardiovascular Devices,
Canada, Category Volume (Units), 2000-2015 59
6.3 Cardiovascular Devices,
Canada, Distribution Share (2007-2008) 64
6.3.1 Cardiac Rhythm Management
Distribution Share (2007-2008) 64
6.3.2 Cardiovascular Monitoring and
Diagnostic Devices Distribution Share (2007-2008) 64
6.3.3 Cardiovascular
Prosthetic Devices Distribution Share (2007-2008) 65
6.3.4 Cardiovascular
Surgery Distribution Share (2007-2008) 65
6.3.5 Electrophysiology
Distribution Share (2007-2008) 66
6.3.6 Interventional Cardiology
Distribution Share (2007-2008) 66
6.3.7 Peripheral Vascular Devices
Distribution Share (2007-2008) 67
6.4 Cardiovascular Devices, Canada,
Company Share (2007-2008) 68
6.4.1 Cardiovascular Devices, Canada, Company
Share (2007-2008) 68
6.4.2 Cardiac Rhythm Management, Canada, Company
Share (2007-2008) 69
6.4.3 Cardiovascular Monitoring and Diagnostic
Devices, Canada, Company Share (2007-2008) 70
6.4.4 Cardiovascular
Prosthetic Devices, Canada, Company Share (2007-2008) 72
6.4.5
Cardiovascular Surgery, Canada, Company Share (2007-2008) 74
6.4.6
Electrophysiology, Canada, Company Share (2007-2008) 75
6.4.7
Interventional Cardiology, Canada, Company Share (2007-2008) 76
6.4.8
Peripheral Vascular Devices, Canada, Company Share (2007-2008) 77
7
Overview of Key Companies in North America Cardiovascular Devices Market
78
7.1 Medtronic, Inc. 78
7.1.1 Company Overview 78
7.1.2 Value
Chain Analysis 78
7.1.3 Medtronic, Inc. Pipeline Products 80
7.2
Boston Scientific Corporation 88
7.2.1 Company Overview 88
7.2.2 Value
Chain Analysis 89
7.2.3 Boston Scientific Corporation Pipeline Products
92
7.3 St. Jude Medical Inc. 98
7.3.1 Company Overview 98
7.3.2
Value Chain Analysis 98
7.3.3 St. Jude Medical Inc. Pipeline Products
101
7.4 Cordis Corporation 104
7.4.1 Company Overview 104
7.4.2
Cordis Corporation Pipeline Products 104
7.5 Biosense Webster, Inc.
106
7.5.1 Company Overview 106
7.6 Abbott Laboratories 107
7.6.1
Company Overview 107
7.6.2 Value Chain Analysis 108
7.7 Terumo
Corporation 111
7.7.1 Company Overview 111
7.7.2 Value Chain Analysis
111
7.7.3 Terumo Corporation Pipeline Products 113
7.8 BIOTRONIK GmbH
& Co. KG 115
7.8.1 Company Overview 115
7.8.2 BIOTRONIK GmbH & Co. KG
Pipeline Products 115
7.9 Sorin S.p.A. 117
7.9.1 Company Overview
117
7.9.2 Value Chain Analysis 118
7.9.3 Sorin Group Pipeline Products
121
7.10 GE Healthcare 124
7.10.1 Company Overview 124
7.11
Philips Healthcare 125
7.11.1 Company Overview 125
7.11.2 Value Chain
Analysis 125
7.11.3 Philips Medical Systems Pipeline Products 128
7.12
OSI Systems, Inc. 130
7.12.1 Company Overview 130
7.12.2 Value Chain
Analysis 131
7.13 Cardiac Science Corporation 133
7.13.1 Company
Overview 133
7.13.2 Value Chain Analysis 134
7.14 Nihon Kohden
Corporation 136
7.14.1 Company Overview 136
7.14.2 Value Chain
Analysis 137
7.15 Welch Allyn Inc. 139
7.15.1 Company Overview 139
7.16 Edwards Lifesciences Corporation 140
7.16.1 Company Overview 140
7.16.2 Value Chain Analysis 140
7.16.3 Edwards Lifesciences Corporation
Pipeline Products 142
7.17 Datascope Corporation 145
7.17.1 Company
Overview 145
7.17.2 Value Chain Analysis 145
7.18 Arrow International,
Inc. 148
7.18.1 Company Overview 148
7.18.2 Value Chain Analysis
149
7.18.3 Arrow International, Inc. Pipeline Products 151
7.19
ABIOMED, Inc. 152
7.19.1 Company Overview 152
7.19.2 Value Chain
Analysis 152
7.19.3 ABIOMED, Inc. Pipeline Products 154
7.20 MAQUET
GmbH & Co. KG 155
7.20.1 Company Overview 155
7.21 AtriCure, Inc.
156
7.21.1 Company Overview 156
7.21.2 AtriCure, Inc. Pipeline
Products 156
7.22 Siemens Healthcare 158
7.22.1 Company Overview
158
7.22.2 Value Chain Analysis 158
7.23 C.R. Bard, Inc. 161
7.23.1 Company Overview 161
7.23.2 Value Chain Analysis 161
7.23.3
C.R. Bard, Inc. Pipeline Products 163
7.24 ev3 Inc. 165
7.24.1 Company
Overview 165
7.24.2 Value Chain Analysis 166
7.24.3 ev3 Inc. Pipeline
Products 168
7.25 Vascular Concepts Limited 170
7.25.1 Company
Overview 170
7.25.2 Vascular Concepts Limited Pipeline Products 170
7.26 Goodman Co., Ltd. 172
7.26.1 Company Overview 172
7.26.2 Goodman
Co., Ltd. Pipeline Products 172
7.27 AtriCure, Inc. 173
7.27.1 Company
Overview 173
7.27.2 AtriCure, Inc. Pipeline Products 173
7.28 JMS CO.,
LTD. 175
7.28.1 Company Overview 175
7.29 ASAHI INTECC CO., LTD.
175
7.29.1 Company Overview 175
7.30 Medical Ventures Corp. 175
7.30.1 Company Overview 175
7.31 Access Point Technologies International
Limited 176
7.31.1 Company Overview 176
7.32 Fukuda Denshi Co., Ltd.
176
7.32.1 Company Overview 176
8 Financial Deals Landscape 177
8.1 Merger 177
8.1.1 Iowa Heart Center to Merge With Mercy Medical Center
177
8.2 Acquisition 178
8.2.1 Covidien To Acquire VNUS Medical
Technologies 178
8.2.2 Medtronic Acquires CoreValve From Sofinnova
Partners, Apax Partners, HealthCap And Maverick Capital 179
8.2.3
CardioNet To Acquire Biotel 181
8.2.4 Vesta Acquires ExtruMed from
Inverness Graham And Wedbush Capital 182
8.2.5 Hansen Medical Invests In
Advanced Cardiac Therapeutics 183
8.3 Partnerships 184
8.3.1 AorTech
International Enters Into Licensing Agreement For Elast-Eon 184
8.3.2
Vicor Technologies Enters Into An Agreement With Nasiff Associates 185
8.3.3 Svelte Medical Systems Enters Into Licensing Agreement With Cordis
186
8.3.4 Welch Allyn Enters Into An Agreement With Schiller 187
8.3.5
LeMaitre Vascular Announces To Terminate Agreement With Edwards Lifesciences
188
9 Recent Developments 189
9.1 Strategy and Business Planning
189
9.1.1 May 21, 2009: Johnson & Johnson Acquires Cougar For $1b 189
9.1.2 May 19, 2009: Elixir Signs Option Agreement with Novartis 189
9.1.3
May 18, 2009: MEI And GE Healthcare Sign Strategic Agreement 189
9.1.4 May
18, 2009: Stentys Launches US Operations In Princeton, New Jersey 190
9.1.5 May 15, 2009: Xtent Board Approves Plan Of Liquidation 190
9.1.6 May
14, 2009: Royal Philips And Hansen Medical To Integrate X-ray Imaging And
Robotic Catheter 191
9.1.7 May 11, 2009: Medtronic Announces San Antonio
As Home Of New Diabetes Facility 191
9.1.8 Apr 13, 2009: St. Jude Medical
Announces Expansion Of Its Liberty Operations 192
9.1.9 Apr 08, 2009:
Philips To Make India Hub For Manufacturing Of Medical Equipment 193
9.1.10 Mar 25, 2009: Medtronic Leases Nearly 50,000 Square-Foot Facility For
Ablation Frontiers Unit 193
9.1.11 Mar 24, 2009: Hospira Announces Plans
To Optimize Operations, Increase Shareholder Value 194
9.1.12 Mar 20,
2009: On-X Life Technologies Doubles Manufacturing Space In Austin 195
9.2
Legal and Regulatory 196
9.2.1 May 19, 2009: L&K Announces Investigation
Against VNUS 196
9.2.2 May 08, 2009: Medtronic And Johnson & Johnson Reach
Agreement On Royalty Disputes 196
9.2.3 May 04, 2009: Attorney General
Cox, Treasurer Kleine Recover $24.5 Million For State Pension Fund 196
9.2.4 Apr 21, 2009: St. Jude Medical Gets FDA Letter On Quality At Minnetonka
Plant 197
9.2.5 Mar 31, 2009: Appeals Court Affirms J&J Stents Infringe
Boston Scientific Patent, Claims Against TAXUS Liberte Dismissed 197
9.2.6
Mar 20, 2009: Boston Scientific Settles Lawsuit With Doctor 198
9.2.7 Mar
16, 2009: OrbusNeich Files Patent Infringement Lawsuit Against Boston
Scientific 198
9.2.8 Mar 11, 2009: Medtronic Announces Dismissal Of
Lawsuit 199
9.2.9 Mar 10, 2009: US District Court Certifies Class Action
In Boston Scientific Securities Lawsuit 199
9.2.10 Mar 04, 2009: DOJ To
Investigate Promotion Of Cardiac-Ablation Therapy 200
9.3 Government and
Public Interest 200
9.3.1 May 28, 2009: FCC May Widen Spectrum For
Wireless Radio Devices 200
9.3.2 May 20, 2009: Defibrillator Act To
Protect People Using Device From Any Possible Legal Action 200
9.3.3 May
14, 2009: EHRA And HRS Release Expert Consensus Statement On The Catheter
Ablation of VT 201
9.3.4 May 13, 2009: HRS Releases Expert Consensus
Statement On Lead Extraction In Patients With Cardiovascular Implantable
Electronic Devices 202
9.3.5 May 13, 2009: HRS Offers First Comprehensive
Guidance On Lead Performance 203
9.3.6 May 07, 2009: FDA Plans National
Registry To Monitor AF Ablation Safety 204
9.3.7 Apr 17, 2009: Draft
Guidance For Industry And FDA Staff: Investigational Device Exemption Guidance
For Retinal Prostheses 204
9.3.8 Apr 07, 2009: Maryland Lawmakers Aims To
Limit Liability For Defibrillator Use 204
9.3.9 Mar 30, 2009:
Cardiologists Worry About Possible Payment Limits To Restrain Health Costs
205
9.3.10 Mar 05, 2009: AdvaMed Sets New Advertising Rules 205
9.4
Product Approvals 206
9.4.1 May 19, 2009: Cardiva Medical Announces FDA
Approval For Catalyst III System 206
9.4.2 May 13, 2009: Rafael Medical
Technologies Receives FDA Clearance For Its SafeFlo Vena Cava Filter 206
9.4.3 May 12, 2009: US FDA Grants Clearance To ATS Medical' s Simulus
Adjustable Annuloplasty Band 207
9.4.4 May 08, 2009: Edwards Lifesciences'
Carpentier-Edwards PERIMOUNT Magna Ease Aortic Valve Receives FDA Approval
207
9.4.5 May 06, 2009: FDA Approves Medtronic Attain Ability Left-Heart
Lead For Cardiac Resynchronization Therapy Devices 208
9.4.6 May 04, 2009:
BioCardia' s Morph AccessPro Steerable Introducer System Gains 510(k) Clearance
209
9.4.7 May 04, 2009: Endosense' s Tacticath Force-Sensing Ablation
Catheter Receives CE Mark 209
9.4.8 Apr 28, 2009: ITGI Medical, Ltd
Receives HUD (Humanitarian Use Device) Designation To Over And Under And
Aneugraft Pericardium Covered Stents From FDA 209
9.4.9 Apr 22, 2009:
Abiomed Announces US 510(K) Approval For Impella 5.0 210
9.4.10 Apr 09,
2009: US FDA Grants Pre-Market Approval For NMT Medical' s STARFlex 210
9.4.11 Apr 06, 2009: Vasomedical Announces Launch Of BIOX Holter Monitoring
Systems And Analysis Software 210
9.4.12 Apr 03, 2009: Berlin Heart
Announces Canadian Approval For EXCOR Pediatric 211
9.4.13 Mar 31, 2009:
Invatec Receives 510(K) Approval For AMPHIRION DEEP Long Balloon To More
Easily Access And Treat Arteries Below The Knee 211
9.4.14 Mar 30, 2009:
Abiomed Announces FDA Approval For New AB Portable Driver 212
9.4.15 Mar
26, 2009: Physio-Control Announces 510(K) Approval Of Its LIFEPAK 15
Monitor/Defibrillator 212
9.4.16 Mar 24, 2009: Gore' s 31 mm Diameter
Version Of The GORE EXCLUDER AAA Endoprosthesis Receives FDA Clearance 213
9.4.17 Mar 23, 2009: Pathway Medical Technologies Announces FDA Approval For
Jetstream G2 System For Thrombectomy 213
9.4.18 Mar 18, 2009: IDEV
Technologies Receives IDE Approval For SUPERA Peripheral Stent 213
9.4.19
Mar 13, 2009: GE Healthcare Announces US FDA Clearance For MAC 800 214
9.4.20 Mar 10, 2009: Endologix Receives FDA Approval For IntuiTrak Express
Delivery System 215
9.4.21 Mar 09, 2009: SyntheMed' s REPEL-CV Adhesion
Barrier Gains FDA Approval For Use In Pediatric Cardiac Surgery 215
10
Appendix 216
10.1 Global Markets Direct Research Methodology 216
10.2
Coverage 217
10.3 Secondary Research 217
10.4 Primary Research 218
10.5 Models 218
10.6 Forecasts 219
10.7 Expert Panel Validation
219
10.8 Currency Conversion 220
10.9 Contact Us 221
10.10
Disclaimer 221
1.1 List of Tables
Table 1:
Cardiovascular Devices, North America, Overall Revenue ($ mn), 2000-2015
19
Table 2: Cardiovascular Devices, North America, Cross-Category
Analysis, 2000-2015 20
Table 3: Cardiovascular Devices, North
America, Overall Revenue ($ mn), Historic, 2000-2008 22
Table 4:
Cardiovascular Devices, North America, Overall Revenue ($ mn), Forecast,
2008-2015 24
Table 5: Cardiovascular Devices, North America, Category
Volume (Units), 2000-2015 25
Table 6: Cardiovascular Devices, North
America, Category Volume (Units), Historic, 2000-2008 27
Table 7:
Cardiovascular Devices, North America, Category Volume (Units), Forecast,
2008-2015 29
Table 8: Cardiovascular Devices, North America, Company
share by Revenue ($ mn), 2007-2008 30
Table 9: Cardiovascular
Devices, United States, Overall Revenue ($ mn), 2000-2015 31
Table 10:
Cardiovascular Devices, United States, Overall Revenue ($ mn), Historic,
2000-2008 33
Table 11: Cardiovascular Devices, United States, Overall
Revenue ($ mn), Forecast, 2008-2015 35
Table 12: Cardiovascular
Devices, United States, Category Volume (Units), 2000-2015 36
Table 13:
Cardiovascular Devices, United States, Category Volume (Units), Historic,
2000-2008 37
Table 14: Cardiovascular Devices, United States,
Category Volume (Units), Forecast, 2008-2015 39
Table 15: Cardiac
Rhythm Management, United States, Distribution Share by Revenue ($mn),
2007-2008 40
Table 16: Cardiovascular Monitoring and Diagnostic
Devices, United States, Distribution Share by Revenue ($mn), 2007-2008 40
Table 17: Cardiovascular Prosthetic Devices, United States, Distribution
Share by Revenue ($mn), 2007-2008 41
Table 18: Cardiovascular
Surgery, United States, Distribution Share by Revenue ($mn), 2007-2008 41
Table 19: Electrophysiology, United States, Distribution Share by Revenue
($mn), 2007-2008 42
Table 20: Interventional Cardiology, United
States, Distribution Share by Revenue ($mn), 2007-2008 42
Table 21:
Peripheral Vascular Devices, United States, Distribution Share by Revenue
($mn), 2007-2008 43
Table 22: Cardiovascular Devices, United States,
Company Share by Revenue ($ mn), 2008-2008 44
Table 23: Cardiac
Rhythm Management, United States, Company Share by Revenue ($ mn), 2007-2008
45
Table 24: Cardiovascular Monitoring and Diagnostic Devices, United
States, Company Share by Revenue ($ mn), 2007-2008 47
Table 25:
Cardiovascular Prosthetic Devices, United States, Company Share by Revenue ($
mn), 2007-2008 49
Table 26: Cardiovascular Surgery, United States,
Company Share by Revenue ($ mn), 2007-2008 50
Table 27:
Electrophysiology, United States, Company Share by Revenue ($ mn), 2007-2008
51
Table 28: Interventional Cardiology, United States, Company Share
by Revenue ($ mn), 2007-2008 52
Table 29: Peripheral Vascular
Devices, United States, Company Share by Revenue ($ mn), 2007-2008 53
Table 30: Cardiovascular Devices, Canada, Overall Revenue ($ mn),
2000-2015 54
Table 31: Cardiovascular Devices, Canada, Overall
Revenue ($ mn), Historic, 2000-2008 56
Table 32: Cardiovascular
Devices, Canada, Overall Revenue ($ mn), Forecast, 2008-2015 58
Table 33:
Cardiovascular Devices, Canada, Category Volume (Units), 2000-2015 59
Table 34: Cardiovascular Devices, Canada, Category Volume (Units),
Historic, 2000-2008 61
Table 35: Cardiovascular Devices, Canada,
Category Volume (Units), Forecast, 2008-2015 63
Table 36: Cardiac
Rhythm Management, Canada, Distribution Share by Revenue ($mn), 2007-2008
64
Table 37: Cardiovascular Monitoring and Diagnostic Devices,
Canada, Distribution Share by Revenue ($mn), 2007-2008 64
Table 38:
Cardiovascular Prosthetic Devices, Canada, Distribution Share by Revenue
($mn), 2007-2008 65
Table 39: Cardiovascular Surgery, Canada,
Distribution Share by Revenue ($mn), 2007-2008 65
Table 40:
Electrophysiology, Canada, Distribution Share by Revenue ($mn), 2007-2008
66
Table 41: Interventional Cardiology, Canada, Distribution Share by
Revenue ($mn), 2007-2008 66
Table 42: Peripheral Vascular Devices,
Canada, Distribution Share by Revenue ($mn), 2007-2008 67
Table 43:
Cardiovascular Devices, Canada, Company Share by Revenue ($ mn), 2007-2008
68
Table 44: Cardiac Rhythm Management, Canada, Company Share by
Revenue ($ mn), 2007-2008 69
Table 45: Cardiovascular Monitoring and
Diagnostic Devices, Canada, Company Share by Revenue ($ mn), 2007-2008 71
Table 46: Cardiovascular Prosthetic Devices, Canada, Company Share by
Revenue ($ mn), 2007-2008 73
Table 47: Cardiovascular Surgery,
Canada, Company Share by Revenue ($ mn), 2007-2008 74
Table 48:
Electrophysiology, Canada, Company Share by Revenue ($ mn), 2007-2008 75
Table 49: Interventional Cardiology, Canada, Company Share by Revenue ($
mn), 2007-2008 76
Table 50: Peripheral Vascular Devices, Canada,
Company Share by Revenue ($ mn), 2007-2008 77
Table 51: Medtronic,
Inc. Pipeline Products by Equipment Type 80
Table 52: Medtronic, Inc.
Pipeline Products by Development Stage 82
Table 53: Medtronic, Inc.
Pipeline Products by Therapy Area 84
Table 54: Medtronic, Inc.
Pipeline Products by Clinical Trials 86
Table 55: Medtronic, Inc.
Pipeline Products by News Summaries 87
Table 56: Boston Scientific
Corporation Pipeline Products by Equipment Type 92
Table 57: Boston
Scientific Corporation Pipeline Products by Development Stage 93
Table 58:
Boston Scientific Corporation Pipeline Products by Therapy Area 94
Table 59: Boston Scientific Corporation Pipeline Products by Clinical
Trials 95
Table 60: Boston Scientific Corporation Pipeline Products
by News Summaries 96
Table 61: St. Jude Medical Inc. Pipeline
Products by Equipment Type 101
Table 62: St. Jude Medical Inc.
Pipeline Products by Development Stage 101
Table 63: St. Jude Medical
Inc. Pipeline Products by Therapy Area 102
Table 64: St. Jude Medical
Inc. Pipeline Products by Clinical Trials 102
Table 65: St. Jude
Medical Inc. Pipeline Products by News Summaries 103
Table 66: Cordis
Corporation Pipeline Products by Equipment Type 104
Table 67: Cordis
Corporation Pipeline Products by Development Stage 104
Table 68:
Cordis Corporation Pipeline Products by Therapy Area 105
Table 69:
Cordis Corporation Pipeline Products by Clinical Trials 105
Table 70:
Cordis Corporation Pipeline Products by News Summaries 105
Table 71:
Terumo Corporation Pipeline Products by Equipment Type 113
Table 72:
Terumo Corporation Pipeline Products by Development Stage 113
Table 73:
Terumo Corporation Pipeline Products by Therapy Area 113
Table 74:
Terumo Corporation Pipeline Products by Clinical Trials 114
Table 75:
Terumo Corporation Pipeline Products by News Summaries 114
Table 76:
BIOTRONIK GmbH & Co. KG Pipeline Products by Equipment Type 115
Table 77:
BIOTRONIK GmbH & Co. KG Pipeline Products by Development Stage 115
Table 78: BIOTRONIK GmbH & Co. KG Pipeline Products by Therapy Area
116
Table 79: BIOTRONIK GmbH & Co. KG Pipeline Products by Clinical
Trials 116
Table 80: BIOTRONIK GmbH & Co. KG Pipeline Products by
News Summary 116
Table 81: Sorin Group Pipeline Products by Equipment
Type 121
Table 82: Sorin Group Pipeline Products by Development Stage
122
Table 83: Sorin Group Pipeline Products by Therapy Area 122
Table 84: Sorin Group Pipeline Products by Clinical Trials 123
Table
85: Sorin Group Pipeline Products by News Summary 123
Table 86:
Philips Medical Systems Pipeline Products by Equipment Type 128
Table 87:
Philips Medical Systems Pipeline Products by Development Stage 128
Table 88: Philips Medical Systems Pipeline Products by Therapy Area
129
Table 89: Philips Medical Systems Pipeline Products by Clinical
Trials 129
Table 90: Philips Medical Systems Pipeline Products by
News Summary 129
Table 91: Edwards Lifesciences Corporation Pipeline
Products by Equipment Type 142
Table 92: Edwards Lifesciences
Corporation Pipeline Products by Development Stage 143
Table 93:
Edwards Lifesciences Corporation Pipeline Products by Therapy Area 143
Table 94: Edwards Lifesciences Corporation Pipeline Products by Clinical
Trials 144
Table 95: Edwards Lifesciences Corporation Pipeline
Products by News Summary 144
Table 96: Arrow International, Inc.
Pipeline Products by Equipment Type 151
Table 97: Arrow
International, Inc. Pipeline Products by Development Stage 151
Table 98:
Arrow International, Inc. Pipeline Products by Therapy Area 151
Table
99: Arrow International, Inc. Pipeline Products by Clinical Trials
151
Table 100: ABIOMED, Inc. Pipeline Products by Equipment Type
154
Table 101: ABIOMED, Inc. Pipeline Products by Development Stage
154
Table 102: ABIOMED, Inc. Pipeline Products by Therapy Area
154
Table 103: ABIOMED, Inc. Pipeline Products by Clinical Trials
155
Table 104: ABIOMED, Inc. Pipeline Products by News Summary
155
Table 105: AtriCure, Inc. Pipeline Products by Equipment Type
156
Table 106: AtriCure, Inc. Pipeline Products by Development Stage
156
Table 107: AtriCure, Inc. Pipeline Products by Therapy Area
157
Table 108: AtriCure, Inc. Pipeline Products by Clinical Trials
157
Table 109: AtriCure, Inc. Pipeline Products by News Summary
157
Table 110: C.R. Bard, Inc. Pipeline Products by Equipment Type
163
Table 111: C.R. Bard, Inc. Pipeline Products by Development Stage
164
Table 112: C.R. Bard, Inc. Pipeline Products by Therapy Area
164
Table 113: C.R. Bard, Inc. Pipeline Products by Clinical Trials
165
Table 114: ev3 Inc. Pipeline Products by Equipment Type 168
Table 115: ev3 Inc. Pipeline Products by Development Stage 168
Table
116: ev3 Inc. Pipeline Products by Therapy Area 169
Table 117:
ev3 Inc. Pipeline Products by Clinical Trials 169
Table 118: ev3 Inc.
Pipeline Products by News Summary 169
Table 119: Vascular Concepts
Limited Pipeline Products by Equipment Type 170
Table 120: Vascular
Concepts Limited Pipeline Products By Development Stage 170
Table 121:
Vascular Concepts Limited Pipeline Products By Therapy Area 171
Table
122: Vascular Concepts Limited Pipeline Products By Clinical Trials
171
Table 123: Goodman Co., Ltd. Pipeline Products by Equipment Type
172
Table 124: Goodman Co., Ltd. Pipeline Products By Development
Stage 172
Table 125: Goodman Co., Ltd. Pipeline Products By Therapy
Area 172
Table 126: Goodman Co., Ltd. Pipeline Products By Clinical
Trials 172
Table 127: AtriCure, Inc. Pipeline Products by Equipment
Type 173
Table 128: AtriCure, Inc. Pipeline Products by Development
Stage 173
Table 129: AtriCure, Inc. Pipeline Products by Therapy Area
174
Table 130: AtriCure, Inc. Pipeline Products by Clinical Trials
174
Table 131: AtriCure, Inc. Pipeline Products by News Summary
174
Table 132: Iowa Heart Center To Merge With Mercy Medical Center
177
Table 133: Covidien To Acquire VNUS Medical Technologies 178
Table 134: Medtronic Acquires CoreValve From Sofinnova Partners, Apax
Partners, HealthCap And Maverick Capital 179
Table 135: CardioNet To
Acquire Biotel 181
Table 136: Vesta Acquires ExtruMed From Inverness
Graham And Wedbush Capital 182
Table 137: Hansen Medical Invests In
Advanced Cardiac Therapeutics 183
Table 138: AorTech International
Enters Into Licensing Agreement For Elast-Eon 184
Table 139: Vicor
Technologies Enters Into An Agreement With Nasiff Associates 185
Table
140: Svelte Medical Systems Enters Into Licensing Agreement With Cordis
186
Table 141: Welch Allyn Enters Into An Agreement With Schiller
187
Table 142: LeMaitre Vascular Announces To Terminate Agreement
With Edwards Lifesciences 188
Table 143: USD to Local Currency, Average
Exchange Rate 2008 220
1.2 List of Figures
Figure 1:
Cardiovascular Devices, North America, Overall Revenue ($ mn), 2000-2015
19
Figure 2: Cardiovascular Devices, North America, Cross-Category
Analysis, 2000-2015 20
Figure 3: Cardiovascular Devices, North
America, Overall Revenue ($ mn), Historic, 2000-2008 21
Figure 4:
Cardiovascular Devices, North America, Overall Revenue ($ mn), Forecast,
2008-2015 23
Figure 5: Cardiovascular Devices, North America,
Category Volume (Units), 2000-2015 25
Figure 6: Cardiovascular
Devices, North America, Category Volume (Units), Historic, 2000-2008 26
Figure 7: Cardiovascular Devices, North America, Category Volume (Units),
Forecast, 2008-2015 28
Figure 8: Cardiovascular Devices, North
America, Company share (%), 2008 30
Figure 9: Cardiovascular Devices,
United States, Overall Revenue ($ mn), 2000-2015 31
Figure 10:
Cardiovascular Devices, United States, Overall Revenue ($ mn), Historic,
2000-2008 32
Figure 11: Cardiovascular Devices, United States,
Overall Revenue ($ mn), Forecast, 2008-2015 34
Figure 12:
Cardiovascular Devices, United States, Category Volume (Units), Forecast,
2008-2015 38
Figure 13: Cardiovascular Devices, United States,
Company Share (%), 2008 44
Figure 14: Cardiac Rhythm Management,
United States, Company Share (%), 2008 45
Figure 15: Cardiovascular
Monitoring and Diagnostic Devices, United States, Company Share (%), 2008
46
Figure 16: Cardiovascular Prosthetic Devices, United States,
Company Share (%), 2008 48
Figure 17: Cardiovascular Surgery, United
States, Company Share (%), 2008 50
Figure 18: Electrophysiology,
United States, Company Share (%), 2008 51
Figure 19: Interventional
Cardiology, United States, Company Share (%), 2008 52
Figure 20:
Peripheral Vascular Devices, United States, Company Share (%), 2008 53
Figure 21: Cardiovascular Devices, Canada, Overall Revenue ($ mn),
2000-2015 54
Figure 22: Cardiovascular Devices, Canada, Overall
Revenue ($ mn), Historic, 2000-2008 55
Figure 23: Cardiovascular
Devices, Canada, Overall Revenue ($ mn), Forecast, 2008-2015 57
Figure 24:
Cardiovascular Devices, Canada, Category Volume (Units), 2000-2015 59
Figure 25: Cardiovascular Devices, Canada, Category Volume (Units),
Historic, 2000-2008 60
Figure 26: Cardiovascular Devices, Canada,
Category Volume (Units), Forecast, 2008-2015 62
Figure 27:
Cardiovascular Devices, Canada, Company Share (%), 2008 68
Figure 28:
Cardiac Rhythm Management, Canada, Company Share (%), 2008 69
Figure 29:
Cardiovascular Monitoring and Diagnostic Devices, Canada, Company Share
(%), 2008 70
Figure 30: Cardiovascular Prosthetic Devices, Canada,
Company Share (%), 2008 72
Figure 31: Cardiovascular Surgery, Canada,
Company Share (%), 2008 74
Figure 32: Electrophysiology, Canada,
Company Share (%), 2008 75
Figure 33: Interventional Cardiology,
Canada, Company Share (%), 2008 76
Figure 34: Peripheral Vascular
Devices, Canada, Company Share (%), 2008 77
Figure 35: Medtronic,
Inc. Value Chain Analysis 78
Figure 36: Boston Scientific Corporation
Value Chain Analysis 89
Figure 37: St. Jude Medical Inc. Value Chain
Analysis 98
Figure 38: Abbott Laboratories Value Chain Analysis
108
Figure 39: Terumo Corporation Value Chain Analysis 111
Figure
40: Sorin Group Value Chain Analysis 118
Figure 41: Philips
Medical Systems Value Chain Analysis 125
Figure 42: OSI Systems, Inc.
Value Chain Analysis 131
Figure 43: Cardiac Science Corporation Value
Chain Analysis 134
Figure 44: Nihon Kohden Corporation Value Chain
Analysis 137
Figure 45: Edwards Lifesciences Corporation Value Chain
Analysis 140
Figure 46: Datascope Corp. Value Chain Analysis 145
Figure 47: Arrow International, Inc. Value Chain Analysis 149
Figure
48: ABIOMED, Inc. Value Chain Analysis 152
Figure 49: Siemens
Medical Solutions Value Chain Analysis 158
Figure 50: C.R. Bard, Inc.
Value Chain Analysis 161
Figure 51: ev3 Inc. Value Chain Analysis
166
Figure 52: Global Markets Direct Methodology 216
|
Related Report
|
View Cart
